Redmile Group
Investor profile
Venture capital
Redmile Group has backed 4 European tech companies across 4 funding rounds between 2017 and 2025, joining rounds totalling €168M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2017–2025
9 yrs
Total round €
€168M
sum of rounds joined
Deals by year
distinct rounds / yearRedmile Group — deals by year — interactive chart.
Data table
| Redmile Group — deals by year | |
|---|---|
| 2017 | 1 |
| 2021 | 2 |
| 2025 | 1 |
Top sectors
by dealsRedmile Group — top sectors — interactive chart.
Data table
| Redmile Group — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsRedmile Group — stages — interactive chart.
Data table
| Redmile Group — stages | |
|---|---|
| Series C | 2 |
| Other | 1 |
| Series A | 1 |
Countries
by dealsRedmile Group — countries — interactive chart.
Data table
| Redmile Group — countries | |
|---|---|
| UK | 3 |
| France | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Evox Therapeutics | UK | 1 | €80M |
| Nightstar | UK | 1 | €39M |
| Sphere Fluidics | UK | 1 | €34M |
| One Biosciences | France | 1 | €15M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Evox Therapeutics | Series C | €80M | 2021-02 |
| Nightstar | Series C | €39M | 2017-07 |
| Sphere Fluidics | Other | €34M | 2021-10 |
| One Biosciences | Series A | €15M | 2025-07 |